# MFHAS1

## Overview
The MFHAS1 gene encodes the multifunctional ROCO family signaling regulator 1, a protein that is part of the ROCO family characterized by the presence of a Ras of complex proteins (ROC) domain and a C-terminal of ROC (COR) domain. This protein is involved in various cellular processes, including innate immunity and macrophage polarization, and is ubiquitously expressed in human tissues. Unlike other ROCO family members, MFHAS1 lacks a kinase domain, which distinguishes its functional profile. The protein plays a critical role in regulating hepcidin expression, a hormone essential for iron metabolism, and modulates inflammatory responses through its interactions with protein phosphatase 2A (PP2A) and other signaling pathways. MFHAS1's involvement in these pathways highlights its significance in both physiological and pathological contexts, including its potential implications in diseases such as sepsis and colorectal cancer (Chen2016MFHAS1; Kumkhaek2019Role; Shi2017MFHAS1).

## Structure
The MFHAS1 protein is a member of the ROCO family and is characterized by several distinct domains. It includes leucine-rich repeats (LRR), a Ras of complex proteins (ROC) domain, and a C-terminal of the ROC (COR) domain, which together form a 'supradomain' typical of ROCO proteins (Marín2008The; Shi2017MFHAS1). The LRR domain is involved in protein-protein interactions and is a common feature in proteins related to the innate immune system (Shi2017MFHAS1). The ROC domain functions as a GTPase, acting as a molecular switch to control protein function and cellular roles (Civiero2014Genetic).

MFHAS1 lacks a kinase domain, which distinguishes it from other ROCO proteins like LRRK and DAPK1 (Marín2008The). The protein's structure is relatively simple compared to other ROCO family members, with the ROC-COR domains preceded by LRRs (Civiero2014Genetic). The interaction of MFHAS1 with other proteins, such as the B and C subunits of PP2A, is mediated through its LRR and ROC domains, highlighting their importance in its functional role (Shi2017MFHAS1). The protein may undergo post-translational modifications, although specific details are not provided in the context.

## Function
The MFHAS1 gene, also known as Malignant Fibrous Histiocytoma Amplified Sequence 1, encodes a protein that is part of the human ROCO protein family, characterized by a Ras of complex proteins (ROC) domain and a C-terminal of ROC (COR) domain. This protein is ubiquitously expressed in various human tissues, including erythroid-lineage cell populations and macrophages, and plays a significant role in innate immunity and macrophage polarization (Kumkhaek2019Role).

In healthy human cells, MFHAS1 is involved in the regulation of hepcidin expression, a key hormone in iron metabolism. It affects hepcidin expression through the BMP/SMAD and MAPK/ERK1/2 signaling pathways. Overexpression of MFHAS1 in human hepatocytes and HuH-7 cells inhibits BMP6 and IL6-stimulated hepcidin mRNA expression, which is associated with decreased phosphorylation of SMAD1/5/9 and increased phosphorylation of ERK1/2. This suggests that MFHAS1 may reduce nuclear translocation of p-SMAD1/5/9, thereby inhibiting hepcidin expression and playing a regulatory role in iron homeostasis (Kumkhaek2019Role).

MFHAS1 is also implicated in the TLR4 signaling pathway, where it acts as a negative regulator by interacting with protein phosphatase 2A (PP2A) subunits, affecting their subcellular localization and activity, which in turn modulates inflammatory responses (Shi2017MFHAS1).

## Clinical Significance
The MFHAS1 gene has been implicated in several diseases due to its role in immune response regulation and inflammation. In the context of sepsis, MFHAS1 is associated with the TLR2 signaling pathway, where it exhibits a dual effect: initially inhibiting inflammation and later promoting it through the activation of the JNK and NF-κB pathways. This dual role suggests that MFHAS1 may contribute to both the systemic inflammatory response syndrome (SIRS) and the compensatory anti-inflammatory response syndrome (CARS) in sepsis, making it a potential biomarker or therapeutic target (Zhong2015MFHAS1).

In colorectal cancer (CRC), MFHAS1 is linked to tumor progression by influencing the polarization of tumor-associated macrophages (TAMs) towards the M2 phenotype, which supports tumor growth and metastasis. This process is mediated through the STAT6 and KLF4 signaling pathways, and higher MFHAS1 expression correlates with advanced CRC stages, suggesting its potential as a biomarker for CRC progression (Chen2016MFHAS1).

MFHAS1 also plays a role in macrophage polarization in inflammatory conditions, such as sepsis, where its ubiquitylation by the E3 ubiquitin ligase praja2 promotes M1 macrophage polarization, enhancing proinflammatory responses (Zhong2017Ubiquitylation).

## Interactions
MFHAS1 interacts with several proteins, playing a significant role in various signaling pathways. It is known to interact with the ubiquitin ligase praja2, which ubiquitylates MFHAS1. This interaction does not lead to MFHAS1 degradation but alters its function, promoting M1 macrophage polarization by activating the JNK and p38 pathways (Zhong2017Ubiquitylation). 

MFHAS1 also interacts with protein phosphatase 2A (PP2A) subunits, specifically the B and C subunits, but not the A subunit. This interaction facilitates the translocation of the PP2A C subunit from the nucleus to the cytoplasm, impacting the TLR4 signaling pathway by inhibiting the dephosphorylation of c-Jun at Thr239, which reduces AP-1 activity and inflammatory cytokine expression (Shi2017MFHAS1). 

Additionally, MFHAS1 has been shown to bind with Hsp70, suggesting potential roles in protein interactions relevant to its function in regulating hepcidin expression through the BMP/SMAD and MAPK/ERK1/2 pathways (Kumkhaek2019Role). These interactions highlight MFHAS1's involvement in modulating inflammatory responses and cellular signaling pathways.


## References


[1. (Kumkhaek2019Role) Chutima Kumkhaek, Christian LaChance, Wulin Aerbajinai, Jianqiong Zhu, and Griffin P. Rodgers. Role of <scp>mfhas</scp>1 in regulating hepcidin expression via the <scp>bmp</scp>/<scp>smad</scp> and <scp>mapk</scp>/<scp>erk</scp>1/2 signalling pathways. British Journal of Haematology, May 2019. URL: http://dx.doi.org/10.1111/bjh.15939, doi:10.1111/bjh.15939. This article has 0 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/bjh.15939)

[2. (Zhong2015MFHAS1) Jing Zhong, Qi-Qing Shi, Min-Min Zhu, Jian Shen, Hui-Hui Wang, Duan Ma, and Chang-Hong Miao. Mfhas1 is associated with sepsis and stimulates tlr2/nf-κb signaling pathway following negative regulation. PLOS ONE, 10(11):e0143662, November 2015. URL: http://dx.doi.org/10.1371/journal.pone.0143662, doi:10.1371/journal.pone.0143662. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0143662)

[3. (Civiero2014Genetic) Laura Civiero, Sybille Dihanich, Patrick A. Lewis, and Elisa Greggio. Genetic, structural, and molecular insights into the function of ras of complex proteins domains. Chemistry &amp; Biology, 21(7):809–818, July 2014. URL: http://dx.doi.org/10.1016/j.chembiol.2014.05.010, doi:10.1016/j.chembiol.2014.05.010. This article has 19 citations.](https://doi.org/10.1016/j.chembiol.2014.05.010)

[4. (Zhong2017Ubiquitylation) Jing Zhong, Huihui Wang, Wankun Chen, Zhirong Sun, Jiawei Chen, Yajun Xu, Meilin Weng, Qiqing Shi, Duan Ma, and Changhong Miao. Ubiquitylation of mfhas1 by the ubiquitin ligase praja2 promotes m1 macrophage polarization by activating jnk and p38 pathways. Cell Death &amp; Disease, 8(5):e2763–e2763, May 2017. URL: http://dx.doi.org/10.1038/cddis.2017.102, doi:10.1038/cddis.2017.102. This article has 49 citations.](https://doi.org/10.1038/cddis.2017.102)

[5. (Chen2016MFHAS1) Wankun Chen, Yajun Xu, Jing Zhong, Huihui Wang, Meilin Weng, Qian Cheng, Qichao Wu, Zhirong Sun, Hui Jiang, Minmin Zhu, Yu Ren, Pingbo Xu, Jiawei Chen, and Changhong Miao. Mfhas1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via stat6 signaling pathway. Oncotarget, 7(48):78726–78735, October 2016. URL: http://dx.doi.org/10.18632/oncotarget.12807, doi:10.18632/oncotarget.12807. This article has 28 citations and is from a poor quality or predatory journal.](https://doi.org/10.18632/oncotarget.12807)

[6. (Marín2008The) Ignacio Marín, Wouter N. Egmond, and Peter J. M. Haastert. The roco protein family: a functional perspective. The FASEB Journal, 22(9):3103–3110, June 2008. URL: http://dx.doi.org/10.1096/fj.08-111310, doi:10.1096/fj.08-111310. This article has 105 citations.](https://doi.org/10.1096/fj.08-111310)

[7. (Shi2017MFHAS1) Qiqing Shi, Bo Xiong, Jing Zhong, Huihui Wang, Duan Ma, and Changhong Miao. Mfhas1 suppresses tlr4 signaling pathway via induction of pp2a c subunit cytoplasm translocation and inhibition of c-jun dephosphorylation at thr239. Molecular Immunology, 88:79–88, August 2017. URL: http://dx.doi.org/10.1016/j.molimm.2017.06.017, doi:10.1016/j.molimm.2017.06.017. This article has 14 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.molimm.2017.06.017)